It is unclear whether d-cycloserine ( DCS ) , a partial N-methyl-d-aspartate agonist that enhances fear extinction , can augment the effects of exposure-based cognitive behavioral therapy ( CBT ) for obsessive-compulsive disorder ( OCD ) .